Eli Lilly licenses Peptron’s SmartDepot by October 7?
One-OffCorporate ActionsBusiness & Corporate28d
PolymarketComprobar disponibilidadSin KYC2% de comisiónDatos de resolución verificadosBien calibradoProbabilidad implícita actual
No 87.1%
Calidad del mercado
≤49 / 100
Baja calidadVolumen 24h
—
Liquidez
1,3 mil €
Baja liquidezCompra / Venta
12.0% / 13.0%
Spread
1.0 pt
Spread estrechoComentarios
0
Datos de mercado
Actualizado hace 5 minutos
6 may 26, 0:05 UTC7 oct 26, 0:00 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Reglas
This market will resolve to “Yes” if Eli Lilly signs a commercial licensing agreement, technology transfer agreement, or equivalent binding agreement with Peptron that grants Eli Lilly commercial rights to Peptron’s SmartDepot technology by the specified date, 11:59 PM Korea Standard Time.
- Otherwise, this market will resolve to “No”.
- Only commercial licensing agreements, technology transfer agreements, or equivalent binding agreements that grant Eli Lilly direct commercial rights to develop, manufacture, sell, or otherwise commercialize Peptron’s SmartDepot technology will qualify.
- Co-development agreements will not qualify.
- Extensions of the existing Technology Evaluation Agreement or other agreements which are non-binding or do not grant Eli Lilly direct commercial rights to SmartDepot will not qualify.
- The primary resolution source for this market will be official information from Eli Lilly and Peptron; however, a consensus of credible reporting may also be used.